当前位置:首页 - 行情中心 - 龙津药业(002750) - 财务分析 - 利润表

龙津药业

(002750)

  

流通市值:29.83亿  总市值:29.96亿
流通股本:3.99亿   总股本:4.01亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入71,053,501.4143,634,125.7521,553,840.94122,965,512.11
营业收入71,053,501.4143,634,125.7521,553,840.94122,965,512.11
利息收入-0--
已赚保费-0--
手续费及佣金收入-0--
二、营业总成本108,601,841.0665,448,598.7732,031,811.64162,500,943.04
营业成本22,138,735.5313,217,116.516,708,989.1825,570,992.68
利息支出-0--
手续费及佣金支出-0--
退保金-0--
赔付支出净额-0--
提取保险合同准备金净额-0--
保单红利支出-0--
分保费用-0--
税金及附加2,509,040.071,719,804.52852,073.723,546,742.58
销售费用48,682,320.1228,473,174.8713,732,557.2480,326,608.24
管理费用23,433,169.9914,651,378.396,946,900.5928,799,189.44
研发费用12,762,122.748,089,166.954,114,891.9924,950,036.68
财务费用-923,547.39-702,042.47-323,601.08-692,626.58
其中:利息费用-0--
其中:利息收入981,020.15743,983.85258,347.1776,405.22
加:公允价值变动收益-9,178.1224,536.3116,039.38264,650.11
加:投资收益3,848,428.392,482,223.51,216,298.267,800,295.26
资产处置收益----177,815.59
资产减值损失(新)-68,606.53-68,667.73-46,175.23-30,215,324.58
信用减值损失(新)39,698.86152,904.72-493,156.07-465,144.04
其他收益2,376,140.121,481,665.44679,951.246,029,161.88
营业利润平衡项目0000
四、营业利润-31,361,856.93-17,741,810.79-9,005,013.12-56,299,607.89
加:营业外收入100,133100,000100,000-
减:营业外支出693.65493.65-12,429,534.07
利润总额平衡项目0000
五、利润总额-31,262,417.58-17,642,304.44-8,905,013.12-68,729,141.96
减:所得税费用1,133,398.86793,133.67509,765.874,799,346.12
六、净利润-32,395,816.44-18,435,438.11-9,414,778.99-73,528,488.08
持续经营净利润-32,395,816.44-18,435,438.11-9,414,778.99-73,528,488.08
归属于母公司股东的净利润-26,642,434.46-15,777,734.45-8,117,275.16-56,116,510.96
少数股东损益-5,753,381.98-2,657,703.66-1,297,503.83-17,411,977.12
(一)基本每股收益-0.07-0.04-0.02-0.14
(二)稀释每股收益-0.07-0.04-0.02-0.14
九、综合收益总额-32,395,816.44-18,435,438.11-9,414,778.99-73,528,488.08
归属于母公司股东的综合收益总额-26,642,434.46-15,777,734.45-8,117,275.16-56,116,510.96
归属于少数股东的综合收益总额-5,753,381.98-2,657,703.66-1,297,503.83-17,411,977.12
公告日期2023-10-312023-08-312023-04-282023-04-21
审计意见(境内)标准无保留意见
TOP↑